Login to Your Account



Week in Washington


Monday, December 19, 2011

The House approved H.R. 1540, the National Defense Authorization Act, which includes an amendment that would finally reauthorize the SBIR program and would allow up to 25 percent of SBIR grants to go to companies that are majority owned by multiple venture capitalists.

An FDA advisory committee debated how to test smallpox drugs under the animal rule when no animal model of the disease exists.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription